<DOC>
	<DOCNO>NCT02149264</DOCNO>
	<brief_summary>This phase 3 , open-label , non-randomized , clinical trial evaluate efficacy safety FE 999303 ( Testosterone gel ) adult hypogonadal male .</brief_summary>
	<brief_title>A Clinical Trial Evaluate Efficacy Safety Testosterone Gel Adult Hypogonadal Males</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Males 1875 year age Two fast serum testosterone level &lt; 300 ng/dL Previous use study drug History prostate breast cancer ProstateSpecific Antigen ( PSA ) â‰¥3 ng/mL Subject sexually active willing use adequate contraception</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>